Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

NCT03226704 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03226704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03226704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Enrolling by invitation
Start date
August 14, 2017
Completion date
July 31, 2030
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, diffuse large b cell lymphoma, leukemia, lymphoma, non-hodgkin's lymphoma